Published March 28, 2026 States move to restrict Delta-8 and similar cannabinoids as legal gray areas shrink Hemp-derived THC products are facing increasing regulation across the United States in 2026, as lawmakers move to address legal gray areas created by the 2018 Farm Bill. Products such as Delta-8, Delta-10, and other hemp-derived cannabinoids have grownContinue reading “U.S. Hemp-Derived THC Products Face Increasing Regulation in 2026”
Category Archives: CBD & Hemp
Explore in-depth coverage of CBD, hemp regulation, and the evolving market for hemp-derived cannabinoid products. This section tracks policy changes, product innovation, and industry trends affecting CBD, Delta-8, hemp-derived THC, and other cannabinoids produced from federally legal hemp.
As lawmakers refine testing standards, licensing requirements, and product safety rules, CBD & Hemp coverage examines how regulatory shifts influence manufacturers, retailers, and consumers. From compliance changes and labeling standards to emerging product categories and wellness market expansion, this section analyzes how hemp continues evolving within the broader cannabis economy.
What This Category Covers
Within CBD & Hemp, readers will find reporting and analysis on topics such as:
Federal and state hemp regulatory updates
CBD product compliance and testing standards
Hemp-derived THC and minor cannabinoid developments
Consumer safety and labeling requirements
Market growth trends and retail expansion
Industry responses to shifting enforcement priorities
As hemp-derived cannabinoids become more integrated into mainstream retail and wellness markets, this category provides insight into the policies, products, and industry forces shaping the sector’s future.
FDA Continues Crackdown on CBD Companies Making Unproven Health Claims
Published March 20, 2026 Federal regulators warn businesses against marketing CBD products with medical benefits The U.S. Food and Drug Administration (FDA) is continuing its enforcement efforts against CBD companies that market products with unproven health claims. Regulators say many businesses are still promoting cannabidiol as a treatment for serious medical conditions without sufficient evidence.Continue reading “FDA Continues Crackdown on CBD Companies Making Unproven Health Claims”
FDA Signals New Direction for CBD Regulation in 2026 as Industry Awaits Clear Rules
Published March 17, 2026 Federal regulators are under growing pressure to establish a national framework for CBD products as the hemp market continues to expand The U.S. Food and Drug Administration is signaling renewed movement on CBD regulation in 2026, as lawmakers and industry stakeholders push for clearer federal rules. Since the passage of theContinue reading “FDA Signals New Direction for CBD Regulation in 2026 as Industry Awaits Clear Rules”
Congress Amendment to Delay Hemp THC Ban Unlikely to Get a Vote, Dampening Industry Hopes
Hemp THC Ban Delay Amendment Faces Long Odds in the 2026 Farm Bill An amendment aimed at delaying the implementation of the federal hemp THC ban is unlikely to receive a vote in the House Agriculture Committee as part of the 2026 Farm Bill process, according to key congressional leadership. The proposed amendment, championed byContinue reading “Congress Amendment to Delay Hemp THC Ban Unlikely to Get a Vote, Dampening Industry Hopes”
Minnesota Lawmakers Consider Delay to In-State Testing Mandate for Hemp-Derived THC Products
State Officials Reevaluate Compliance Timeline Amid Lab Capacity Concerns Minnesota cannabis regulators and lawmakers are proposing a legislative delay to the state’s in-state testing requirement for hemp-derived THC products, lawmakers confirmed in February 2026. The proposal aims to temporarily permit accredited out-of-state laboratories to test products like low-dose THC seltzers and gummies through summer 2027,Continue reading “Minnesota Lawmakers Consider Delay to In-State Testing Mandate for Hemp-Derived THC Products”
New Federal Hemp Crackdown in 2026 Could Remove Most THC Products From Market
Federal Hemp Law Changes Signal Major Shift for Cannabis and CBD Products The federal government is preparing to implement stricter hemp regulations in 2026 that could significantly reshape the cannabis and CBD product landscape. These changes come as lawmakers and regulators move to tighten the legal definition of hemp and limit the sale of certainContinue reading “New Federal Hemp Crackdown in 2026 Could Remove Most THC Products From Market”
FDA Faces Critical Deadline as New Federal Hemp and CBD Rules Take Shape in 2026
Federal Hemp and CBD Regulations Enter a New Phase in 2026 The hemp and CBD industry is entering a critical new phase in 2026 as federal regulators move forward with updated rules that could significantly reshape how hemp-derived cannabinoid products are defined, packaged, and sold across the United States. These regulatory developments mark one ofContinue reading “FDA Faces Critical Deadline as New Federal Hemp and CBD Rules Take Shape in 2026”
FDA Issues New Warning on Hemp-Derived THC Edibles as Consumption Surges Nationwide
Federal Health Officials Sound the Alarm The U.S. Food and Drug Administration has issued a renewed consumer warning regarding hemp-derived THC edibles, citing growing concerns over product safety, inconsistent potency, and a sharp rise in adverse health reports. As delta-8 THC gummies, baked goods, beverages, and candies continue to gain popularity nationwide, federal regulators sayContinue reading “FDA Issues New Warning on Hemp-Derived THC Edibles as Consumption Surges Nationwide”
Federal Lawmakers Propose Bipartisan Bill to Regulate Hemp Products, Counteracting 2026 Ban
Congressional Lawmakers File Bipartisan Bill In a significant move for the hemp industry, bipartisan members of the U.S. Congress have introduced legislation aimed at regulating consumable hemp products at the federal level, starkly contrasting with the federal ban on intoxicating hemp products included in last year’s spending package. The new bill, unveiled in January 2026,Continue reading “Federal Lawmakers Propose Bipartisan Bill to Regulate Hemp Products, Counteracting 2026 Ban”
U.S. Senators Push Legislation to Protect Hemp and CBD Products from Federal Ban
Hemp Industry Faces Federal Threat, Lawmakers Respond The American hemp and CBD market — valued at billions and supporting hundreds of thousands of jobs — is facing an unprecedented regulatory threat after Congress included language in a recent spending bill that effectively bans most hemp-derived products under federal law. In response, U.S. Senators Ron WydenContinue reading “U.S. Senators Push Legislation to Protect Hemp and CBD Products from Federal Ban”